Results 71 to 80 of about 6,323,480 (352)

Putting women’s eyesight first

Community Eye Health Journal, 2016
Two-thirds of blindness and visual impairment occurs in women, and recent prevalence surveys in Vietnam and China show an imbalance in the coverage of services across some areas.
Damian Facciolo , Camille Neyhouser
doaj  

Evaluation of integrated care: ensuring rigor, scaling up, scaling out

International Journal of Integrated Care, 2019
Health systems face significant challenges in moving towards integrated care. Despite long time policy pressures and the existence of best practice models at international level, integrated care frequently remains limited to pilot projects.
Oliver Groene
doaj   +1 more source

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma [PDF]

, 2020
Elaine S. Jaffe, Binita S. Ashar, Mark W. Clemens, Andrew L. Feldman, Philippe Gaulard, Roberto N. Miranda, Aliyah R. Sohani, Timothy T. Stenzel, Sung Woon Yoon   +8 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

V německých lesních školkách vládne rozmanitost a pohoda

Envigogika, 2015
Pedagogové lesních mateřských škol z celé České republiky vyrazili za kolegy do Berlína. Během jednoho lednového týdne navštívili pět lesních mateřských škol a centrum výzkumu pro děti Helleum.
Tereza Valkounová
doaj   +1 more source

Best practices in pain assessment and management for children [PDF]

, 2022
Evelyne D Trottier, Samina Ali, Marie‐Joëlle Doré‐Bergeron, Laurel Chauvin‐Kimoff   +3 more
openalex   +1 more source

Working to End Homelessness Initiative: Best Practice Series [PDF]

, 2012
The Working to End Homelessness: Best Practice Series highlights lessons learned from these efforts and the research literature. This series is intended for employment and homeless service providers, program staff, and policymakers who want to learn more

core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source